We are live on ! Find out more
KCM

Kingdon Capital Management Portfolio holdings

AUM $911M
1-Year Est. Return 51.11%
This Fund
S&P 500
This Quarter Est. Return
-6.26%
1 Year Est. Return
+51.11%
3 Year Est. Return
+185.44%
5 Year Est. Return
+284.29%
10 Year Est. Return
+2,022.7%
AUM
$2.07B
AUM Growth
-$484M
Cap. Flow
-$243M
Cap. Flow %
-11.71%
Top 10 Hldgs %
39.78%
Holding
174
New
48
Increased
26
Reduced
40
Closed
49

Top Buys

Rank Stock Value
1
GOOG icon
Alphabet (Google) Class C
GOOG
+$61.5M
2
ANAC
ANACOR PHARMACEUTICALS INC COM
ANAC
+$53.8M
3
PYPL icon
PayPal
PYPL
+$44.3M
4
PNK
Pinnacle Entertainment Inc.
PNK
+$34.6M
5
AXTA icon
Axalta
AXTA
+$33.4M

Top Sells

Rank Stock Value
1
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$65.6M
2
TSN icon
Tyson Foods
TSN
+$57.2M
3
SUNE
SUNEDISON, INC COM
SUNE
+$38.5M
4
EBAY icon
eBay
EBAY
+$29M
5
HLT icon
Hilton Worldwide
HLT
+$28.3M

Sector Composition

Rank Sector Weight
1 Healthcare 12.1%
2 Consumer Staples 7.63%
3 Consumer Discretionary 7.38%
4 Industrials 5.06%
5 Financials 3.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MDWD icon
101
MediWound
MDWD
$185M
$2.39M 0.12%
44,786
-214
-0.5% -$10.5K
JAGX icon
102
Jaguar Health
JAGX
$4.76M
– –
0
– –
OTIC
103
DELISTED
Otonomy, Inc.
OTIC
$1.96M 0.09%
+110,000
New +$2.6M
NUVA
104
DELISTED
NuVasive, Inc.
NUVA
$1.95M 0.09%
40,500
– –
CLVS
105
DELISTED
Clovis Oncology, Inc.
CLVS
$1.89M 0.09%
+20,600
New +$1.78M
CBAY
106
DELISTED
Cymabay Therapeutics
CBAY
$1.84M 0.09%
+950,000
New +$2.59M
SGYP
107
DELISTED
Synergy Pharmaceuticals, Inc Common Stock
SGYP
$1.8M 0.09%
+340,000
New +$2.63M
TPST icon
108
CALL
Tempest Therapeutics
TPST
$14.7M
$1.7M 0.08%
68
-161
-70% -$10.8M
CIVI
109
DELISTED
Civitas Solutions, Inc.
CIVI
$1.7M 0.08%
74,050
– –
UHS icon
110
Universal Health Services
UHS
$10.5B
$1.64M 0.08%
13,100
-5,000
-28% -$696K
SUNE
111
DELISTED
SUNEDISON, INC COM
SUNE
$1.62M 0.08%
225,000
-2,145,032
-91% -$38.5M
ITCI
112
DELISTED
Intra-Cellular Therapies Inc.
ITCI
$1.6M 0.08%
+40,000
New +$1.3M
RPRX
113
CALL
DELISTED
Repros Therapeutics Inc.
RPRX
$1.49M 0.07%
+200,000
New +$1.53M
CEMP
114
DELISTED
Cempra, Inc.
CEMP
$1.39M 0.07%
+50,000
New +$1.86M
AAPL icon
115
Apple
AAPL
$4.51T
$1.24M 0.06%
+45,008
New +$1.32M
QLIK
116
DELISTED
QLIK TECHNOLOGIES INC COM STK (DE)
QLIK
$1.18M 0.06%
32,359
-721,079
-96% -$27.9M
RCKT icon
117
Rocket Pharmaceuticals
RCKT
$378M
$1.08M 0.05%
+28,750
New +$1.32M
ETFC
118
DELISTED
E*Trade Financial Corporation
ETFC
$1.04M 0.05%
39,570
-160,430
-80% -$4.45M
GBT
119
DELISTED
Global Blood Therapeutics, Inc.
GBT
$852K 0.04%
+20,200
New +$953K
AAL icon
120
American Airlines Group
AAL
$11.1B
$608K 0.03%
450,000
– –
EXEL icon
121
CALL
Exelixis
EXEL
$14.1B
$561K 0.03%
+100,000
New +$544K
ADVM
122
CALL
DELISTED
Adverum Biotechnologies
ADVM
– –
-14,000
Closed -$2.27M
ALB icon
123
Albemarle
ALB
$14.2B
– –
-50,000
Closed -$2.76M
AMPH icon
124
Amphastar Pharmaceuticals
AMPH
$887M
– –
-206,539
Closed -$3.63M
BLUE
125
DELISTED
bluebird bio
BLUE
– –
-11,473
Closed -$25M
3 4
5
6 7

Similar funds

GC
Greenvale Capital London, United Kingdom $912M AUM 34.2% 1-Year Est. Return
ICP
Ironvine Capital Partners Omaha, Nebraska $910M AUM 10.64% 1-Year Est. Return
NAM
NTV Asset Management Charleston, West Virginia $910M AUM 27.02% 1-Year Est. Return
SAA
Southeast Asset Advisors Thomasville, Georgia $913M AUM 25.32% 1-Year Est. Return
GIG
Goodnow Investment Group Darien, Connecticut $913M AUM 11.84% 1-Year Est. Return
SI
Symmetry Investments St Helier, Jersey $913M AUM 30.59% 1-Year Est. Return
PAMI
Perseverance Asset Management International George Town, Cayman Islands $909M AUM 17.42% 1-Year Est. Return
BDP
Brehaut David Pascal $908M AUM

Kingdon Capital Management's Q3 2015 Portfolio in Review

As of Q3 2015, Kingdon Capital Management held 174 positions worth $2.07B, down 19% from $2.56B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Kingdon Capital Management withdrew a net $243M in Q3 2015, closing 49 positions and reducing 40 holdings. Its most notable exit was eBay, an estimated $29M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, down from 21% a quarter earlier, followed by Consumer Staples and Consumer Discretionary.

Against the trend, Kingdon Capital Management opened a new position in Alphabet (Google) Class C worth $63.9M.

  • Kingdon Capital Management's largest Q3 2015 buy was Alphabet (Google) Class C: 2,001,820 shares worth $63.9M.
  • Kingdon Capital Management added most to ANACOR PHARMACEUTICALS INC COM in Q3 2015, an estimated $53.8M increase.
  • Kingdon Capital Management's biggest Q3 2015 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $65.6M.
  • Kingdon Capital Management fully exited eBay in Q3 2015, selling an estimated $29M.
  • Kingdon Capital Management's ten largest holdings make up 40% of its $2.07B portfolio in Q3 2015.
  • Kingdon Capital Management opened 48 new positions and closed 49 in Q3 2015.
  • Kingdon Capital Management's portfolio value fell 19% quarter-over-quarter to $2.07B.

Based on Kingdon Capital Management's 13F filing for Q3 2015, filed 16 Nov 2015.